Quantum BioPharma Dividends and Buybacks
Dividend criteria checks 0/6
Quantum BioPharma does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-87.5%
Buyback Yield
| Total Shareholder Yield | -87.5% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
FSD Pharma receives Nasdaq minimum bid price deficiency notification
Sep 29FSD Pharma gets clearance to start phase 2 trial of FSD201 in US, Canada
Sep 06FSD Pharma names Adnan Bashir as independent director
Jun 03FSD Pharma submits FSD201 IND to treat gastrointestinal enteropathy in dogs
May 10FSD Pharma appoints interim CFO
May 05Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if QNTM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if QNTM's dividend payments have been increasing.
Dividend Yield vs Market
| Quantum BioPharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (QNTM) | n/a |
| Market Bottom 25% (US) | 1.3% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (QNTM) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate QNTM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate QNTM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate QNTM's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as QNTM has not reported any payouts.